Investigación > Cáncer

Grupo de investigación de biomarcadores en cáncer (GReBiC)

Número de publicaciones
507
Buscador de publicaciones

  • Porcel, L; Alas, S; Bielsa, S; Porcel, JM

    Yield of ultrasound-guided biopsies of focal lesions in an internal medicine department

    REVISTA CLINICA ESPANOLA 225 502285-502285. .

    [doi:10.1016/j.rce.2025.502285]

  • Berm dez, M; Gonz lez, JD; Chine, E; Torne, O; Bernard, P; Tueros, L; V zquez, S; Garc a, V; Garc a, ME; Baquedano, JE; Mira, M; Bonet, M

    Phytotherapy and Pre-Probiotics as a Potential Approach to Improve Gastrointestinal Symptoms in Prostate Cancer Patients Undergoing Radiotherapy

    RADIOTHERAPY AND ONCOLOGY 206 1936-1938. .

  • Porcel, JM; Trujillano, J; Porcel, L; Esquerda, A; Bielsa, S

    Development and validation of a diagnostic prediction model for heart failure-related pleural effusions: the BANCA score

    ERJ Open Research 11 -. .

    [doi:10.1183/23120541.01030-2024]

  • Olivares-Gazca, J; Fern ndez-Lara, D; Porcel, J; Robles-Hern ndez, R; Lira-Lara, O; Perez, MMG; Garcia-V lez, D; Cruz-P rez, G; Delgado, GR; Ruiz-Arg elles, G

    Association of Smoking with Disease Progression in Persons with Multiple Sclerosis Undergoing Autologous Hematopoietic Cell Transplantation: A Single-Center Experience

    MULTIPLE SCLEROSIS JOURNAL 31 244-244. .

  • Rendon-Ramírez, EJ; Alvarez-Martinez, N; Solis, RC; Vaquera-Alfaro, HA; Olivo-Gutiérrez, MC; Nañez-Terreros, H; González-Aguirre, JE; Mercado-Longoria, R; Colunga-Pedraza, PR; Manjarrez-Granados, EA; González-Garza, JA; Juarez, SBM; Porcel, JM

    Thoracic ultrasound in hemodialysis: Assessing fluid overload and dialysis efficacy

    Medicine 104 -. .

    [doi:10.1097/MD.0000000000042023]

  • Valladares-Ayerbes M; Toledano-Fonseca M; Graña B; Jimenez-Fonseca P; Pulido-Cortijo G; Gil S; Sastre J; Salud A; Rivera F; Salgado M; García-Alfonso P; López López R; Guillén-Ponce C; Rodríguez-Ariza A; Vieitez JM; Díaz-Rubio E; Aranda E

    Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer.

    Bmc Cancer 25 743-743. .

    [doi:10.1186/s12885-025-14098-9]

  • López-Fernández, A; Duran-Lozano, L; Villacampa, G; Pardo, M; Pérez, E; Darder, E; Vallmajó, A; Alfonso, R; Cruellas, M; Roqué, A; Cartró, M; Bareas, A; Carrasco, E; Rezqallah, A; Jimenez-Macedo, AR; Torres-Esquius, S; Torres, M; Lopez, C; Espinosa, M; Teulé, A; Munté, E; Tuset, N; Diez, O; Feliubadaló, L; Lázaro, C; Llort, G; Carver, T; Ficorella, L; Mavaddat, N; Mercadé, A; Antoniou, AC; Brunet, J; Cajal, TRY; Balmaña, J

    A randomized study of 2 risk assessment models for individualized breast cancer risk estimation

    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 117 1593-1604. .

    [doi:10.1093/jnci/djaf067]

  • Gómez, JC; Viñas, MMC; Pérez, JMP; Bailón, MM; Martínez, PP; Marín, MTH; del Prado, N; Somoza, FJE

    RECALMIN V. Evolution in the activity of internal medicine units of the National Health System (2007-2022)

    REVISTA CLINICA ESPANOLA 225 211-222. .

    [doi:10.1016/j.rce.2024.10.011]

  • Porcel, JM

    The internist as an expert in invasive ultrasound: Breaking barriers

    MEDICINA CLINICA 164 292-294. .

    [doi:10.1016/j.medcli.2024.12.007]

  • Rodriguez, JV; Piñol, M; Sorolla, MA; Parisi, E; Sorolla, A; Santacana, M; Ruiz, M; Parra, G; Bernabeu, M; Iglesias, M; Aracil, C; Escartin, A; VILARDELL, F; Matias-Guiu, X; Salud, A; Montal, R

    Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies

    Journal for ImmunoTherapy of Cancer 13 -. .

    [doi:10.1136/jitc-2024-010024]

  • Xu, CM; Mannucci, A; Esposito, F; Oliveres, H; Alonso-Orduña, V; Yubero, A; Fernández-Martos, C; Salud, A; Gallego, J; Martín-Richard, M; Fernández-Plana, J; Guillot, M; Aparicio, J; Fakih, M; Kopetz, S; Feliu, J; Maurel, J; Goel, A

    An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study

    CLINICAL CANCER RESEARCH 31 1002-1015. .

    [doi:10.1158/1078-0432.CCR-24-1934]

  • Pérez-García J.M.; Gion M.; Ruiz-Borrego M.; Blancas I.; López-Miranda E.; Blanch S.; Recalde S.; Rendo C.R.; González X.; Ancizar N.; Morales S.; Cortez P.; Piwowarska Z.; Shimizu E.; Guerrero J.A.; Sampayo-Cordero M.; Martínez-Bueno A.; Cortés J.; Llombart-Cussac A.

    Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial

    Eclinicalmedicine 85 103309-103309. .

    [doi:10.1016/j.eclinm.2025.103309]